Azione 301047 SINO BIOLOGICAL,INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Sino Biological,Inc.

Azioni

301047

CNE100004Q23

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 30/04/2024 		Variaz. 5gg Var. 1 gen.
70,51 CNY -0,14% Grafico intraday di Sino Biological,Inc. +2,62% -14,43%
28/04 Sino Biological,Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
26/04 Sino Biological,Inc. (SZSE:301047) ha completato l'acquisizione di SignalChem Biotech Inc. da Signalchem Lifesciences Corporation. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological,Inc. completed the acquisition of SignalChem Biotech Inc. from Signalchem Lifesciences Corporation.
Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2023
Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024.
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological,Inc. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024.
Bio-Link Pharmaceutical Technology Co., Ltd. announced that it has received funding from Cathay Capital Private Equity SAS, Sino Biological,Inc., Suzhou GSL Venture Capital Management Company, Beijing GSR United Capital Management Consulting Co., Ltd., Tianjin Qianxi Investment Management Partnership Ent. (L.P.), Shanghai Pudong Haiwang Private Fund Management Co., Ltd. and other investors
Sino Biological,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Sino Biological to Acquire Canada’s SignalChem Biotech for $48 Million
Sino Biological,Inc. entered into Share Purchase Agreement to acquire SignalChem Biotech Inc. from Signalchem Lifesciences Corporation for CAD 65.85 million.
Sino Biological: new US centre for bioprocessing
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological,Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Sino Biological Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2023.
Sino Biological Unit to Lease Beijing Property to Shenzhou Cell Engineering
Sino Biological Buys Land for 918 Million Yuan
Sino Biological,Inc Approves the Final Cash Dividend for the Year 2022, Payable on 24 May 2023
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 301047
  4. Notizie Sino Biological,Inc.
  5. Altre lingue